University of California San Francisco
Give to UCSF
Displaying 901 - 930 of 1111
-
-
Archive: New Lung Cancer Test Predicts Survival
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.
-
Archive: Many Breast Cancer Patients Uninformed About Options: Study
-
Archive: Some Breast Cancer Spread May Be Triggered By Targetable Protein, Study Shows
Scientists from the University of Helsinki, Finland, and UCSF have identified a cleaver-wielding protein that frees some tumor cells, allowing them to further misbehave. The discovery points to a new target for therapy.
-
Archive: Smoking Pot Doesn't Hurt Lung Capacity, Study Shows
-
Archive: Tobacco Firm Skewed Toxicology Findings
-
Archive: Nicotine Patches, Gums Won't Help Smokers Quit Long-Term
-
Archive: Treatment Fails to Preserve Ovarian Function After Chemotherapy
-
Archive: The Tobacco Industry Lied
-
Archive: Don't Believe Hype About Robot Prostatectomy: Study
-
Archive: Cancer Researchers Win Grants
-
Archive: UCSF Cancer-Drug Spinoff Acquired for $190 Million
<p>A cancer drug company founded by UCSF Professor <a href="http://cancer.ucsf.edu/people/shokat_kevan.php">Kevan Shokat</a>, PhD, has been acquired by Japan-based Takeda Pharmaceuticals in an effort to add two novel drug projects to Takeda’s pipeline of potential oncology therapies.</p>
-
Archive: I'm Feeling Healthy
-
Archive: Glioblastoma Multiforme Brain Tumors
-
Archive: Breast Cancer Trial Could Speed approval of New Drugs
-
Archive: Opting to Track, Not Treat, Early Prostate Cancer
-
Archive: New Moves To Fast Track Breast Cancer Drug Trials
-
Archive: SF Businessman, Philanthropist, Bluegrass Man Warren Hellman Dies at 77
-
Archive: UCSF's Blackburn Inducted into the California Hall of Fame
<p>UCSF Nobel laureate Elizabeth Blackburn, PhD, whose co-discovery of an enzyme involved in cell aging and cancers opened a whole new field of scientific inquiry, was inducted into the <a href="">California Hall of Fame</a> on Dec. 8, 2011. </p>
-
Archive: Marijuana, Narcotics Help Patients Reduce Chronic Pain, Study Finds
-
Archive: Pot, Narcotics OK to Treat Pain, UCSF Study Finds
-
Archive: Life Choices Dwarf Pollutants in Breast Cancer Risk, Report Finds
-
Archive: UCSF Study Finds Medical Marijuana Could Help Patients Reduce Pain with Opiates
A UCSF study suggests patients with chronic pain may experience greater relief if their doctors add cannabinoids – the main ingredient in cannabis or medical marijuana – to an opiates-only treatment.
-
Archive: Stanford, UCSF Recruit Cancer Patients for Trials
-
Archive: Stanford, UCSF to Test Ultrasound for Cancer Pain
-
Archive: Cancer's Escape Routes
-
Archive: Cold Caps Aim to Preserve Hair for Cancer Patients
-
Archive: Push Is on to Stay One Step Ahead of Cancer
-
Archive: Glassybaby Inspired by Fight Against Cancer
-
Archive: Well-Done Red Meat Linked With Aggressive Prostate Cancer, Study Shows